Risk factors for HIV virological non-suppression among adolescents with common mental disorder symptoms in Zimbabwe: a cross-sectional study.


Journal

Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566

Informations de publication

Date de publication:
08 2021
Historique:
revised: 10 06 2021
received: 25 09 2020
accepted: 05 07 2021
entrez: 17 8 2021
pubmed: 18 8 2021
medline: 27 10 2021
Statut: ppublish

Résumé

Adolescents are at increased risk of HIV virological non-suppression compared to adults and younger children. Common mental disorders such as anxiety and depression are a barrier to adherence and virological suppression. The aim of this study was to identify factors associated with virological non-suppression among adolescents living with HIV (ALWH) in Zimbabwe who had symptoms of common mental disorders. We utilized baseline data from a cluster-randomized controlled trial of a problem-solving therapy intervention to improve mental health and HIV viral suppression of ALWH. Sixty clinics within 10 districts were randomized 1:1 to either the intervention or control arm, with the aim to recruit 14 adolescents aged 10 to 19 per clinic. Adolescents were eligible if they scored ≥7 on the Shona Symptom Questionnaire measuring symptoms of common mental disorders. Multivariable mixed-effects logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (95% CI) for factors associated with non-suppression, defined as viral load ≥1000 copies/mL. Between 2 January and 21 March 2019 the trial enrolled 842 participants aged 10 to 19 years (55.5% female, 58.8% aged <16). Most participants (N = 613) were taking an NNRTI-based ART regimen (13 PI-based, 216 unknown) and median duration on ART was six years (IQR three to nine years, 240 unknown). Of the 833 with viral load data 292 (35.1%) were non-suppressed. Virological non-suppression was independently associated with male sex (adjusted OR (aOR) = 1.43, 95% CI 1.04 to 1.97), and with not knowing one's own HIV status (aOR = 1.77, 95% CI 1.08 to 2.88), or knowing one's status but not disclosing it to anyone (aOR = 1.99, 95% CI 1.36 to 2.93), compared to adolescents who knew their status and had disclosed it to someone. ALWH with symptoms of common mental disorders have high prevalence of virological non-suppression in Zimbabwe, especially if they do not know their status or have not disclosed it. In general adolescents should be informed of their HIV status, with encouragement on the beneficial health and social effects of viral suppression, to incentivise adherence. Efforts to strengthen the operationalization of disclosure guidelines for adolescents should now be prioritized.

Identifiants

pubmed: 34402199
doi: 10.1002/jia2.25773
pmc: PMC8368838
doi:

Substances chimiques

Anti-HIV Agents 0

Banques de données

PACTR
['PACTR201810756862405']

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

e25773

Subventions

Organisme : Medical Research Council
ID : MR/R010161/1
Pays : United Kingdom

Informations de copyright

© 2021 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.

Références

PLoS One. 2015 Dec 14;10(12):e0144057
pubmed: 26658814
J Dev Behav Pediatr. 2016 Jul-Aug;37(6):496-505
pubmed: 27262128
Br J Psychiatry. 2015 Sep;207(3):262-8
pubmed: 26045350
AIDS Behav. 2016 Sep;20(9):1841-50
pubmed: 26837624
HIV Med. 2019 Mar;20(3):248-253
pubmed: 30632659
Rev Med Chil. 2018 Apr;146(4):479-486
pubmed: 29999123
PLoS One. 2014 Jan 27;9(1):e87322
pubmed: 24475271
Lancet Glob Health. 2020 Feb;8(2):e264-e275
pubmed: 31924539
BMC Infect Dis. 2017 May 3;17(1):326
pubmed: 28468608
AIDS Care. 2016;28 Suppl 3:67-73
pubmed: 27421053
AIDS Care. 2018 Jul;30(7):830-835
pubmed: 29397759
J Int AIDS Soc. 2018 Jul;21 Suppl 4:e25137
pubmed: 30027621
AIDS Care. 2015;27(7):805-16
pubmed: 25702789
AIDS. 2020 Jun 1;34(7):1065-1074
pubmed: 32287060
Int J Environ Res Public Health. 2019 Mar 04;16(5):
pubmed: 30836611
AIDS Res Hum Retroviruses. 2020 Jul;36(7):566-573
pubmed: 32138527
J Int AIDS Soc. 2013 May 27;16:18466
pubmed: 23714198
Front Public Health. 2017 Dec 13;5:343
pubmed: 29326918
Trop Med Int Health. 2016 Mar;21(3):325-33
pubmed: 26681359
Popul Health Metr. 2003 Dec 16;1(1):11
pubmed: 14678566
Afr J AIDS Res. 2012 Oct;11(3):261-71
pubmed: 25860100
J Int AIDS Soc. 2017 Dec;20(4):
pubmed: 29219248
AIDS Behav. 2019 Feb;23(2):513-522
pubmed: 30132172
AIDS. 2015 Jun;29 Suppl 1:S57-65
pubmed: 26049539
J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):355-64
pubmed: 26181708
Bull World Health Organ. 2010 Nov 1;88(11):815-23
pubmed: 21076562
AIDS Behav. 2017 Jan;21(1):59-69
pubmed: 27395433
Vulnerable Child Youth Stud. 2016 Jan 2;11(1):60-68
pubmed: 27019666
PLoS One. 2017 Oct 9;12(10):e0183180
pubmed: 28991913
BMC Health Serv Res. 2019 Nov 28;19(1):905
pubmed: 31779631
PLoS One. 2020 Mar 2;15(3):e0228601
pubmed: 32119663
BMC Public Health. 2018 Oct 4;18(1):1158
pubmed: 30286746
Lancet HIV. 2019 Apr;6(4):e211-e213
pubmed: 30772420
J Int AIDS Soc. 2017 May 16;20(Suppl 3):21497
pubmed: 28530045
BMC Infect Dis. 2020 Jan 2;20(1):4
pubmed: 31898535
Int J Environ Res Public Health. 2019 Feb 18;16(4):
pubmed: 30781717
BMC Psychiatry. 2015 Oct 26;15:264
pubmed: 26503291
J Int AIDS Soc. 2020 Sep;23 Suppl 5:e25552
pubmed: 32869514
BMC Public Health. 2016 Feb 29;16:197
pubmed: 26927422
AIDS Care. 2015;27 Suppl 1:6-17
pubmed: 26616121
J Affect Disord. 2016 Jul 1;198:50-5
pubmed: 27011359
Glob Ment Health (Camb). 2020 Aug 28;7:e23
pubmed: 32963795
Sociol Health Illn. 2015 Feb;37(2):270-83
pubmed: 25421409
Medicine (Baltimore). 2019 Jun;98(23):e15994
pubmed: 31169739
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Afr J AIDS Res. 2014;13(2):189-95
pubmed: 25174636
J Acquir Immune Defic Syndr. 2017 May 1;75(1):18-26
pubmed: 28114186
AIDS Care. 2020 Jan;32(1):104-112
pubmed: 31554414
AIDS Care. 2012;24(6):722-7
pubmed: 22292411
J Clin Nurs. 2012 Sep;21(17-18):2438-51
pubmed: 22765309
Med Anthropol. 2017 Jul;36(5):485-499
pubmed: 28379042

Auteurs

Victoria Simms (V)

MRC International Statistics and Epidemiology Group, London School of Hygiene & Tropical Medicine, London, UK.

Sarah Bernays (S)

London School of Hygiene & Tropical Medicine, London, UK.

Dixon Chibanda (D)

London School of Hygiene & Tropical Medicine, London, UK.
Friendship Bench, Harare, Zimbabwe.
Department of Psychiatry, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.

Silindweyinkosi Chinoda (S)

Friendship Bench, Harare, Zimbabwe.

Rhulani Beji-Chauke (R)

Friendship Bench, Harare, Zimbabwe.

Owen Mugurungi (O)

AIDS & TB Unit, Ministry of Health and Child Care, Harare, Zimbabwe.

Tsitsi Apollo (T)

AIDS & TB Unit, Ministry of Health and Child Care, Harare, Zimbabwe.

Dorcas Sithole (D)

Mental Health Services, Ministry of Health and Child Care, Harare, Zimbabwe.

Ruth Verhey (R)

Friendship Bench, Harare, Zimbabwe.

Helen A Weiss (HA)

MRC International Statistics and Epidemiology Group, London School of Hygiene & Tropical Medicine, London, UK.

Nicola Willis (N)

Africaid, Harare, Zimbabwe.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH